Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
BOW
|
Stephen Jay Sills
CEO and President |
SELL
Bona fide gift
|
Direct | 12,431 Reduced 1.2% |
-
|
Jul 15
2025 |
BOW
|
Stephen Jay Sills
CEO and President |
BUY
Bona fide gift
|
Indirect | 12,431 Added 0.0% |
-
|
Jul 15
2025 |
PAPL
|
Kendall Leo Marin
COO |
BUY
Open market or private purchase
|
Direct | 81,000 Added 3.29% |
$8,100
$0.1 p/Share
|
Jul 15
2025 |
CIFR
|
Top Hold Co B.V. Bitfury
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 289,145 Reduced 0.0% |
$1,752,218
$6.06 p/Share
|
Jul 15
2025 |
LEG
|
Benjamin Michael Burns
Executive Vice President - CFO |
BUY
Grant, award, or other acquisition
|
Direct | 175 Added 0.12% |
$1,412
$8.07 p/Share
|
Jul 15
2025 |
MKL
|
Andrew G. Crowley
President, Markel Ventures |
BUY
Other acquisition or disposition
|
Direct | 5 Added 0.25% |
$8,896
$1779.25 p/Share
|
Jul 15
2025 |
CXM
|
Sanjay Macwan
Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct | 60,000 Added 16.67% |
-
|
Jul 15
2025 |
BARK
|
Allison Koehler
Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,192 Reduced 0.3% |
$1,907
$0.87 p/Share
|
Jul 15
2025 |
HGTY
|
Robert I Kauffman
Director |
SELL
Open market or private sale
|
Indirect | 14,862 Reduced 0.0% |
$148,620
$10.0 p/Share
|
Jul 15
2025 |
BKKT
|
Karen Alexander
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 671 Reduced 0.95% |
$12,218
$18.21 p/Share
|
Jul 15
2025 |
MRVI
|
Peter Michael Leddy
Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 5,154 Reduced 0.7% |
$13,348
$2.59 p/Share
|
Jul 15
2025 |
DNIF
|
Winmill & Co. Inc |
BUY
Open market or private purchase
|
Direct | 10,000 Added 4.9% |
$135,500
$13.55 p/Share
|
Jul 15
2025 |
DT
|
Stephen Eric Rowland
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 431 Added 2.49% |
-
|
Jul 15
2025 |
TTWO
|
Ellen F Siminoff
Director |
SELL
Open market or private sale
|
Indirect | 414 Reduced 0.0% |
$98,449
$237.8 p/Share
|
Jul 15
2025 |
RPD
|
Scott M Murphy
Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 343 Reduced 0.97% |
$7,727
$22.53 p/Share
|
Jul 15
2025 |
XPEL
|
Ryan Pape
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 254 Reduced 0.02% |
$8,902
$35.05 p/Share
|
Jul 15
2025 |
XPEL
|
Ryan Pape
President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 1,040 Added 0.1% |
-
|
Jul 15
2025 |
APLS
|
Cedric Francois
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 1,900 Reduced 0.55% |
$38,171
$20.09 p/Share
|
Jul 15
2025 |
APLS
|
Cedric Francois
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 800 Added 0.23% |
$3,447
$4.31 p/Share
|
Jul 15
2025 |
MCO
|
Robert Fauber
President and CEO |
SELL
Open market or private sale
|
Direct | 415 Reduced 0.67% |
$208,911
$503.4 p/Share
|
Jul 15
2025 |
MCO
|
Robert Fauber
President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 281 Added 0.45% |
$27,006
$96.11 p/Share
|
Jul 15
2025 |
XPEL
|
Barry Wood
Senior Vice President/CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 181 Reduced 0.65% |
$6,344
$35.05 p/Share
|
Jul 15
2025 |
XPEL
|
Barry Wood
Senior Vice President/CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 743 Added 2.61% |
-
|
Jul 15
2025 |
RAPP
|
David Bredt
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 8,500 Reduced 1.92% |
$119,000
$14.0 p/Share
|
Jul 15
2025 |
KFS
|
Kent A Hansen
CFO & EVP |
BUY
Open market or private purchase
|
Direct | 108 Added 0.08% |
$1,564
$14.49 p/Share
|
Jul 15
2025 |
LWLG
|
Ronald A Bucchi
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 20,162 Added 10.31% |
-
|
Jul 15
2025 |
LWLG
|
Thomas M Connelly Jr
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 20,162 Added 38.91% |
-
|
Jul 15
2025 |
LWLG
|
Craig Ciesla
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 20,162 Added 24.62% |
-
|
Jul 15
2025 |
LWLG
|
Siraj Nour El Ahmadi
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 20,162 Added 15.67% |
-
|
Jul 15
2025 |
LWLG
|
Laila Partridge
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 20,162 Added 31.6% |
-
|
Jul 15
2025 |
INCY
|
Steven H Stein
EVP & Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct | 12,277 Added 10.33% |
-
|
Jul 15
2025 |
INCY
|
Steven H Stein
EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,596 Reduced 1.66% |
$108,927
$68.25 p/Share
|
Jul 15
2025 |
BLND
|
Brian Kneafsey
Head of Revenue |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 3.35% |
$90,750
$3.63 p/Share
|
Jul 15
2025 |
INSP
|
Georgia Melenikiotou
Director |
BUY
Grant, award, or other acquisition
|
Direct | 131 Added 3.37% |
$16,768
$128.0 p/Share
|
Jul 15
2025 |
ZSPC
|
Paul Kellenberger
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 1,407 Reduced 5.87% |
$3,925
$2.79 p/Share
|
Jul 15
2025 |
DRCT
|
W Keith Smith
President |
SELL
Open market or private sale
|
Indirect | 8,100 Reduced 0.0% |
$4,374
$0.54 p/Share
|
Jul 15
2025 |
DRCT
|
Mark D Walker
Chairman and CEO |
SELL
Open market or private sale
|
Indirect | 8,066 Reduced 0.0% |
$4,355
$0.54 p/Share
|
Jul 15
2025 |
INCY
|
Pablo J Cagnoni
President, R&D |
BUY
Grant, award, or other acquisition
|
Direct | 17,538 Added 6.95% |
-
|
Jul 15
2025 |
INCY
|
Pablo J Cagnoni
President, R&D |
SELL
Payment of exercise price or tax liability
|
Direct | 2,628 Reduced 1.2% |
$179,361
$68.25 p/Share
|
Jul 15
2025 |
CNDT
|
A. Scott Letier
Director |
BUY
Grant, award, or other acquisition
|
Direct | 14,605 Added 2.35% |
$38,265
$2.62 p/Share
|
Jul 15
2025 |
INSP
|
Shelley G. Broader
Director |
BUY
Grant, award, or other acquisition
|
Direct | 148 Added 3.47% |
$18,944
$128.0 p/Share
|
Jul 15
2025 |
INSP
|
Casey M Tansey
Director |
BUY
Grant, award, or other acquisition
|
Direct | 133 Added 0.6% |
$17,024
$128.0 p/Share
|
Jul 15
2025 |
INSP
|
Gary Lee Ellis
Director |
BUY
Grant, award, or other acquisition
|
Direct | 221 Added 3.51% |
$28,288
$128.0 p/Share
|
Jul 15
2025 |
GLW
|
Jaymin Amin
SVP and Chief Tech. Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 10,210 Reduced 9.5% |
$536,229
$52.52 p/Share
|
Jul 15
2025 |
WAY
|
Matthew J. Hawkins
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 46,667 Reduced 5.76% |
$1,785,479
$38.26 p/Share
|
Jul 15
2025 |
WAY
|
Matthew J. Hawkins
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 46,667 Added 5.44% |
$193,201
$4.14 p/Share
|
Jul 15
2025 |
INCY
|
Herve Hoppenot
Special Advisor to the CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 4,713 Reduced 0.9% |
$321,662
$68.25 p/Share
|
Jul 15
2025 |
INCY
|
Barry P Flannelly
EVP & General Manager US |
SELL
Payment of exercise price or tax liability
|
Direct | 1,141 Reduced 3.03% |
$77,873
$68.25 p/Share
|
Jul 15
2025 |
INCY
|
Barry P Flannelly
EVP & General Manager US |
SELL
Open market or private sale
|
Direct | 1,192 Reduced 3.07% |
$83,273
$69.86 p/Share
|
Jul 15
2025 |
INCY
|
Vijay K Iyengar
EVP, GMAPPS |
SELL
Payment of exercise price or tax liability
|
Direct | 836 Reduced 2.33% |
$57,057
$68.25 p/Share
|
Jul 15
2025 |